Suppr超能文献

超广谱β-内酰胺酶:一种迫在眉睫的危险?

ESBLs: A Clear and Present Danger?

作者信息

Dhillon Rishi H-P, Clark John

机构信息

Department of Medical Microbiology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK.

出版信息

Crit Care Res Pract. 2012;2012:625170. doi: 10.1155/2012/625170. Epub 2011 Jun 6.

Abstract

Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher morbidity and mortality and greater fiscal burden. Coupled with increasing prevalence rates worldwide and an ever diminishing supply in the antibiotic armamentarium, these enzymes represent a clear and present danger to public health. This article aims to give an overview of the current situation regarding ESBLs, with a focus on the epidemiology and management of such infections.

摘要

超广谱β-内酰胺酶(ESBLs)是由多种革兰氏阴性菌产生的酶,这些酶会使细菌对常用抗生素的耐药性增强。它们是一个令人担忧的全球公共卫生问题,因为由产生此类酶的生物体引起的感染与更高的发病率、死亡率以及更大的财政负担相关。再加上全球发病率不断上升以及抗生素储备供应不断减少,这些酶对公众健康构成了明显的现实威胁。本文旨在概述超广谱β-内酰胺酶的现状,重点关注此类感染的流行病学和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8452/3135063/ff2ea251d3de/CCRP2012-625170.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验